Antifungal attributes of immunosuppressive agents: new paradigms in management and elucidating the pathophysiologic basis of opportunistic mycoses in organ transplant recipients1
Authors:
- Joseph HeitmanJHJoseph Heitman
- 27 March 2004
- journal article
- review article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 77 (6) , 795-800
Abstract
The currently available immunosuppressive agents cyclosporine A, tacrolimus, and rapamycin have potent antifungal activity against a number of opportunistic fungi in organ transplant recipients, most notably, C. neoformans, Candida, and Aspergillus species. The targets of their antifungal acitivity are fungal homologs of the signaling molecules that mediate their immunosuppressive action in humans, which has implications for further unraveling the pathogenesis of these infections. Corroborative clinical data suggest that despite the apparent paradox between the antifungal activity of the immunosuppressive agents and the occurrence of fungal infections during their administration, the antifungal attributes of these drugs may influence the spectrum and clinical characteristics of these infections after organ transplantation. Finally, the potent synergistic interactions between the immunosuppressive agents and antifungal drugs against many pathogenic fungi, including those that are typically resistant to traditional antifungal agents, could potentially have a role in devising novel therapeutic strategies for opportunistic mycoses in transplant recipients.Keywords
This publication has 50 references indexed in Scilit:
- Changes in the spectrum and risk factors for invasive candidiasis in liver transplant recipients: prospective, multicenter, case-controlled study1Transplantation, 2003
- The Clinical Epidemiology of Pulmonary Cryptococcosis in Non-AIDS Patients at a Tertiary Care Medical CenterMedicine, 2001
- Cryptococcus neoformansInfection in Organ Transplant Recipients: Variables Influencing Clinical Characteristics and OutcomeEmerging Infectious Diseases, 2001
- Antifungal Prophylaxis for Solid Organ Transplant Recipients: Seeking Clarity Amidst ControversyClinical Infectious Diseases, 2000
- Invasive Aspergillosis in Transplant RecipientsMedicine, 1999
- Fungal Infections in Lung and Heart-Lung Transplant Recipients: Report of 9 Cases and Review of the LiteratureMedicine, 1996
- Factors Associated with the Development of Candidemia and Candidemia-Related Death Among Liver Transplant RecipientsAnnals of Surgery, 1996
- THE ANTIMICROBIAL ACTIVITIES OF CYCLOSPORINE, FK506, AND RAPAMYCINTransplantation, 1994
- Fungal Infections in Solid-Organ TransplantationClinical Infectious Diseases, 1993
- Infections after Liver TransplantationMedicine, 1988